참고문헌
- Covas DT, Panepucci RA, Fontes AM, et al (2008). Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. Exp Hematol, 36, 642-54. https://doi.org/10.1016/j.exphem.2007.12.015
- Cronwright G, Le Blanc K, Gotherstrom C, et al (2005). Cancer/testis antigen expression in human mesenchymal stem cells: down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression. Cancer Res, 65, 2207-15. https://doi.org/10.1158/0008-5472.CAN-04-1882
- Curiel TJ (2007). Tregs and rethinking cancer immunotherapy. J Clin Invest, 117, 1167-74. https://doi.org/10.1172/JCI31202
- De Miguel MP, Fuentes-Julian S, Blazquez-Martinez A, et al (2012). Immunosuppressive properties of mesenchymal stem cells: advances and applications. Curr Mol Med, 12, 574-91. https://doi.org/10.2174/156652412800619950
- Dianatpour M, Mehdipour P, Nayernia K, et al (2012). Expression of testis specific Genes TSGA10, TEX101 and ODF3 in breast cancer. Iran Red Crescent Med J, 14, 722-6.
- Ghafouri-Fard S (2012a). Are cancer-testis antigens cancer stem cell markers. Single Cell Biol, 1, 104.
- Ghafouri-Fard S (2012b). Immunotherapy in nonmelanoma skin cancer. Immunotherapy, 4, 499-510. https://doi.org/10.2217/imt.12.29
- Ghafouri-Fard S, Abbasi A, Moslehi H, et al (2010). Elevated expression levels of testis-specific genes TEX101 and SPATA19 in basal cell carcinoma and their correlation with clinical and pathological features. Br J Dermatol, 162, 772-9.
- Ghafouri-Fard S, Abdollahi DZ, Omrani M, et al (2012). shRNA mediated RHOXF1 silencing influences expression of BCL2 but not CASP8 in MCF-7 and MDA-MB-231 cell lines. Asian Pac J Cancer Prev, 13, 5865-9. https://doi.org/10.7314/APJCP.2012.13.11.5865
- Ghafouri-Fard S, Modarressi MH (2009). Cancer-testis antigens: potential targets for cancer immunotherapy. Arch Iran Med, 12, 395-404.
- Ghafouri-Fard S, Modarressi MH (2012). Expression of cancer-testis genes in brain tumors: implications for cancer immunotherapy. Immunotherapy, 4, 59-75. https://doi.org/10.2217/imt.11.145
- Ghafouri-Fard S, Modarressi MH, Yazarloo F (2012b). Expression of testis-specific genes, TEX101 and ODF4, in chronic myeloid leukemia and evaluation of TEX101 immunogenicity. Ann Saudi Med, 32, 256-61.
- Ghafouri-Fard S, Ousati Ashtiani Z, Sabah Golian B, et al (2010b). Expression of two testis-specific genes, SPATA19 and LEMD1, in prostate cancer. Arch Med Res, 41, 195-200. https://doi.org/10.1016/j.arcmed.2010.04.003
- Hayes SJ, Hng KN, Clark P, et al (2014). Immunohistochemical assessment of NY-ESO-1 expression in esophageal adenocarcinoma resection specimens. World J Gastroenterol, 20, 4011-6. https://doi.org/10.3748/wjg.v20.i14.4011
- Jorgensen C, Djouad F, Apparailly F, et al (2003). Engineering mesenchymal stem cells for immunotherapy. Gene Ther, 10, 928-31. https://doi.org/10.1038/sj.gt.3302019
- Lifantseva N, Koltsova A, Krylova T, et al (2011). Expression patterns of cancer-testis antigens in human embryonic stem cells and their cell derivatives indicate lineage tracks. Stem cells international, 2011.
- Saldanha-Araujo F, Haddad R, Zanette DL, et al (2010). Cancer/Testis antigen expression on mesenchymal stem cells isolated from different tissues. Anticancer Res, 30, 5023-7.
- Steinbach D, Hermann J, Viehmann S, et al (2002). Clinical implications of PRAME gene expression in childhood acute myeloid leukemia. Cancer Genetics Cytogenetics, 133, 118-23. https://doi.org/10.1016/S0165-4608(01)00570-2
- Tabarestani S, Ghafouri-Fard S (2012). Cancer stem cells and response to therapy. Asian Pac J Cancer Prev, 13, 5951-8.
- Yamada R, Takahashi A, Torigoe T, et al (2013). Preferential expression of cancer/testis genes in cancer stem-like cells: proposal of a novel sub-category, cancer/testis/stem gene. Tissue Antigens, 81, 428-34. https://doi.org/10.1111/tan.12113
- Yawata T, Nakai E, Park KC, et al (2010). Enhanced expression of cancer testis antigen genes in glioma stem cells. Mol Carcinog, 49, 532-44 https://doi.org/10.1002/mc.20614
피인용 문헌
- Expression analysis of cancer-testis genes in prostate cancer reveals candidates for immunotherapy vol.9, pp.12, 2017, https://doi.org/10.2217/imt-2017-0083
- Melanoma: a prototype of cancer-testis antigen-expressing malignancies vol.9, pp.13, 2017, https://doi.org/10.2217/imt-2017-0091